Log In
BCIQ
Print this Print this
 

SAR-20347

  Manage Alerts
Collapse Summary General Information
Company Sareum Holdings plc
DescriptionTyrosine kinase 2 (TYK2) and janus kinase-1 (JAK-1) inhibitor
Molecular Target Tyrosine kinase 2 (TYK2) ; Janus kinase-1 (JAK-1)
Mechanism of ActionJanus kinase-2 (JAK-2) inhibitor; Tyrosine kinase receptor 2 (Tie2) inhibitor
Therapeutic Modality 

 Product Details
Disease CategoryStandard IndicationIndication DetailsPartnersMilestonesLatest Stage of DevelopmentRegulatory Designation
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today